JP2016518452A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016518452A5 JP2016518452A5 JP2016514093A JP2016514093A JP2016518452A5 JP 2016518452 A5 JP2016518452 A5 JP 2016518452A5 JP 2016514093 A JP2016514093 A JP 2016514093A JP 2016514093 A JP2016514093 A JP 2016514093A JP 2016518452 A5 JP2016518452 A5 JP 2016518452A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- item
- composition according
- salt
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361823766P | 2013-05-15 | 2013-05-15 | |
| US61/823,766 | 2013-05-15 | ||
| PCT/US2014/038211 WO2014186581A1 (en) | 2013-05-15 | 2014-05-15 | Cenicriviroc compositions and methods of making and using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016518452A JP2016518452A (ja) | 2016-06-23 |
| JP2016518452A5 true JP2016518452A5 (https=) | 2017-06-08 |
| JP6391674B2 JP6391674B2 (ja) | 2018-09-19 |
Family
ID=51898872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016514093A Expired - Fee Related JP6391674B2 (ja) | 2013-05-15 | 2014-05-15 | セニクリビロック組成物並びにその製造及び使用方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20160081985A1 (https=) |
| EP (1) | EP2996694A4 (https=) |
| JP (1) | JP6391674B2 (https=) |
| KR (1) | KR20160013068A (https=) |
| CN (1) | CN105263498B (https=) |
| AU (1) | AU2014265327B2 (https=) |
| BR (1) | BR112015028644A2 (https=) |
| CA (1) | CA2911212A1 (https=) |
| CL (1) | CL2015003346A1 (https=) |
| IL (1) | IL242394B (https=) |
| MX (1) | MX383706B (https=) |
| MY (1) | MY180145A (https=) |
| PH (1) | PH12015502539A1 (https=) |
| RU (1) | RU2633069C2 (https=) |
| SG (2) | SG10201708595YA (https=) |
| UA (1) | UA115807C2 (https=) |
| WO (1) | WO2014186581A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2206702B1 (en) | 2001-08-08 | 2011-12-28 | Tobira Therapeutics, Inc. | Bicyclic compound, production and use thereof |
| EP3119401A4 (en) * | 2014-03-21 | 2017-12-13 | Tobira Therapeutics, Inc. | Cenicriviroc for the treatment of fibrosis |
| EP3777863A1 (en) * | 2014-09-12 | 2021-02-17 | Tobira Therapeutics, Inc. | Cenicriviroc combination therapy for the treatment of fibrosis |
| BR112017013130A2 (pt) * | 2014-12-23 | 2017-12-26 | Tobira Therapeutics Inc | processo de fabricação de cenicriviroc e análogos relacionados |
| ES2864767T3 (es) * | 2015-02-10 | 2021-10-14 | Tobira Therapeutics Inc | Composición que comprende cenicriviroc y ácido fumárico para su uso en el tratamiento de lesiones hepáticas agudas o peritonitis |
| WO2016135740A1 (en) * | 2015-02-23 | 2016-09-01 | Natco Pharma Limited | Process for preparing stable oral compositions of everolimus |
| JP2018532720A (ja) * | 2015-09-16 | 2018-11-08 | トビラ セラピューティクス， インコーポレイテッド | 線維症の治療のためのセニクリビロック併用療法 |
| BR112018076449A2 (pt) * | 2016-06-21 | 2019-04-09 | Tobira Therapeutics, Inc. | cenicriviroc purificado e intermediários purificados para fazer cenicriviroc |
| BR112019002132A2 (pt) | 2016-08-08 | 2019-05-14 | Hetero Labs Limited | composições anti-retrovirais |
| JP2019526628A (ja) | 2016-08-31 | 2019-09-19 | トビラ セラピューティクス， インコーポレイテッド | セニクリビロクメシレートの固体形態及びセニクリビロクメシレートの固体形態を製造するプロセス |
| US10736905B1 (en) | 2016-09-09 | 2020-08-11 | Shahin Fatholahi | Nefopam dosage forms and methods of treatment |
| SG11201910173YA (en) | 2017-05-11 | 2019-11-28 | Univ King Abdullah Sci & Tech | Device and method for microfluidics-based 3d bioprinting |
| KR102611274B1 (ko) | 2017-05-11 | 2023-12-07 | 킹 압둘라 유니버시티 오브 사이언스 앤드 테크놀로지 | 조직 가공 및 바이오프린팅 시 사용하기 위한 겔을 형성할 수 있는 펩타이드 |
| RU2662160C9 (ru) * | 2017-07-03 | 2018-10-22 | Александрович Иващенко Андрей | Комбинированный лекарственный препарат для терапии вирусных инфекций |
| US11446311B2 (en) | 2017-09-08 | 2022-09-20 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
| US10736874B1 (en) | 2017-09-08 | 2020-08-11 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
| WO2021133811A1 (en) * | 2019-12-26 | 2021-07-01 | Teva Pharmaceuticals International Gmbh | Solid state forms of cenicriviroc and process for preparation thereof |
| EP4093380A1 (en) | 2020-01-23 | 2022-11-30 | Lupin Limited | Pharmaceutical compositions of raltegravir |
| US12590121B2 (en) | 2020-08-20 | 2026-03-31 | King Abdullah University Of Science And Technology | Peptide compound with repetitive sequences |
| US12109327B2 (en) | 2020-08-20 | 2024-10-08 | King Abdullah University Of Science And Technology | Scaffolds from self-assembling tetrapeptides support 3D spreading, osteogenic differentiation and angiogenesis of mesenchymal stem cells |
| US11673324B2 (en) | 2020-08-20 | 2023-06-13 | King Abdullah University Of Science And Technology | Nozzle for 3D bioprinting |
| JP2022108727A (ja) * | 2021-01-13 | 2022-07-26 | 日曹商事株式会社 | フマル酸含有固形製剤 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2167649C2 (ru) * | 1995-08-11 | 2001-05-27 | Ниссан Кемикал Индастриз, Лтд. | Способ получения твердой дисперсии умеренно водорастворимого лекарственного вещества (варианты) и фармацевтическая композиция |
| KR100571613B1 (ko) * | 1997-10-20 | 2006-04-17 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 안정화 의약 조성물 |
| CA2244097A1 (en) * | 1998-08-21 | 2000-02-21 | Bernard Charles Sherman | Pharmaceutical composition comprising bupropion hydrochloride and fumaric acid |
| ATE275392T1 (de) * | 1999-04-12 | 2004-09-15 | Shionogi & Co | Verfahren zur herstellung von arzneimitteln eines basischen hydrophoben wirkstoffs |
| JPWO2006059716A1 (ja) * | 2004-12-03 | 2008-06-05 | 武田薬品工業株式会社 | 固形製剤 |
| MA34215B1 (fr) * | 2010-04-02 | 2013-05-02 | Phivco 1 Llc | Traitement d'association comprenant un antagoniste du récepteur ccr5, un inhibiteur de la protéase du vih-1 et un accélérateur pharmacocinétique |
| EP3119401A4 (en) * | 2014-03-21 | 2017-12-13 | Tobira Therapeutics, Inc. | Cenicriviroc for the treatment of fibrosis |
-
2014
- 2014-05-15 SG SG10201708595YA patent/SG10201708595YA/en unknown
- 2014-05-15 MX MX2015015500A patent/MX383706B/es unknown
- 2014-05-15 JP JP2016514093A patent/JP6391674B2/ja not_active Expired - Fee Related
- 2014-05-15 KR KR1020157035069A patent/KR20160013068A/ko not_active Ceased
- 2014-05-15 US US14/891,019 patent/US20160081985A1/en not_active Abandoned
- 2014-05-15 UA UAA201512359A patent/UA115807C2/uk unknown
- 2014-05-15 CN CN201480027717.3A patent/CN105263498B/zh active Active
- 2014-05-15 CA CA2911212A patent/CA2911212A1/en not_active Abandoned
- 2014-05-15 RU RU2014150327A patent/RU2633069C2/ru active
- 2014-05-15 AU AU2014265327A patent/AU2014265327B2/en not_active Ceased
- 2014-05-15 EP EP14797645.0A patent/EP2996694A4/en not_active Withdrawn
- 2014-05-15 MY MYPI2015703958A patent/MY180145A/en unknown
- 2014-05-15 SG SG11201509136YA patent/SG11201509136YA/en unknown
- 2014-05-15 BR BR112015028644A patent/BR112015028644A2/pt not_active Application Discontinuation
- 2014-05-15 WO PCT/US2014/038211 patent/WO2014186581A1/en not_active Ceased
-
2015
- 2015-11-02 IL IL242394A patent/IL242394B/en active IP Right Grant
- 2015-11-05 PH PH12015502539A patent/PH12015502539A1/en unknown
- 2015-11-13 CL CL2015003346A patent/CL2015003346A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016518452A5 (https=) | ||
| RU2014150327A (ru) | Композиции ценикривирока и способы их получения и применения | |
| RU2015110699A (ru) | Фармацевтическая антиретровирусная композиция | |
| KR102058097B1 (ko) | 다루나비어 복합 제제 | |
| JP2011098964A5 (https=) | ||
| JP2006516570A5 (https=) | ||
| US10842751B2 (en) | Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine | |
| JP2019516674A5 (https=) | ||
| JP2015521191A5 (https=) | ||
| CA2779052A1 (en) | Pharmaceutical composition of entecavir and process of manufacturing | |
| JP2021532193A5 (https=) | ||
| JP2016175932A (ja) | ｐＨの影響を改善したアタザナビル硫酸塩製剤 | |
| US9757340B2 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
| EP3326619B1 (en) | Solid oral pharmaceutical compositions comprising tenofovir and emtricitabine | |
| KR20160060764A (ko) | 아타자나비르 및 코비시스타트의 ｈｉｖ 치료 제제 | |
| AU2016231883B2 (en) | Pharmaceutical compositions of dimethyl fumarate | |
| JP2016527237A5 (https=) | ||
| JP2015221782A (ja) | モンテルカストナトリウム含有製剤 | |
| EP3496719B1 (en) | A multi-class anti-retroviral composition | |
| US20150141376A1 (en) | Pharmaceutical compositions of anti-viral compounds and process for preparation thereof | |
| EP3383402B1 (en) | Pharmaceutical composition comprising darunavir and method for the preparation thereof | |
| JP5910311B2 (ja) | 医薬錠剤およびその製造方法 | |
| WO2018029566A1 (en) | A high drug loaded tablet composition for treating hiv | |
| HK40114875A (en) | Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine | |
| AU2024357464A1 (en) | Pharmaceutical compositions containing doravirine and islatravir |